Biosurgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Biosurgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

The global biosurgery market reached a value of US$ 12.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2027, exhibiting a CAGR of 6.95% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Biosurgery is a medical procedure that involves the use of natural, synthetic or semi-synthetic materials to seal surgical incisions and wounds. It is widely used for preventing excessive blood loss, providing adhesion for wound or tissue sealing and repairing damaged tissues and bones. Biosurgeries are usually conducted through various hemostatic, sealant, soft tissue repair, bone graft substitute, adhesion prevention and staple line reinforcement products. They also utilize natural allografts, cultured epithelial autografts and xenografts for minimizing intra and post-operative complications and promoting faster recovery of the patients. As a result, they are widely used for neurological, cardiovascular, orthopedic, spinal, thoracic and reconstruction surgeries.

Biosurgery Market Trends:
The increasing prevalence of musculoskeletal disorders that require treatment through surgical procedures is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more prone to osteoporosis and other chronic medical ailments, is providing a thrust to the market growth. Patients and healthcare providers are widely adopting biosurgeries for effective blood loss management in patients through minimally invasive (MI) hemostatic agents and surgical sealants in place of traditionally used sutures and staples. In line with this, the rising incidents of sports-related injuries and accidental traumas is also contributing to the growth of the market. Additionally, various technological advancements, such as the development of plasma-based, multi-functional and multi-use products for biosurgeries, are favoring the growth of the market. Other factors, including significant improvements in the healthcare infrastructure, especially in the developing economies, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biosurgery market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, source, application and end user.

Breakup by Product:

Bone-Graft Substitutes
Soft-Tissue Attachments
Hemostatic Agents
Surgical Sealants and Adhesives
Adhesion Barriers
Staple Line Reinforcement

Breakup by Source:

Natural/Biologics Products
Synthetic Products

Breakup by Application:

Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Gynecological Surgery

Breakup by End User:


Breakup by Region:

North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.
Key Questions Answered in This Report:
How has the global biosurgery market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global biosurgery market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the source?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global biosurgery market and who are the key players?
What is the degree of competition in the industry?

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biosurgery Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Bone-Graft Substitutes
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Soft-Tissue Attachments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Hemostatic Agents
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Surgical Sealants and Adhesives
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Adhesion Barriers
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Staple Line Reinforcement
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Source
7.1 Natural/Biologics Products
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Synthetic Products
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Orthopedic Surgery
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 General Surgery
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Neurological Surgery
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular Surgery
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Gynecological Surgery
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States Market Trends Market Forecast
10.1.2 Canada Market Trends Market Forecast
10.2 Asia-Pacific
10.2.1 China Market Trends Market Forecast
10.2.2 Japan Market Trends Market Forecast
10.2.3 India Market Trends Market Forecast
10.2.4 South Korea Market Trends Market Forecast
10.2.5 Australia Market Trends Market Forecast
10.2.6 Indonesia Market Trends Market Forecast
10.2.7 Others Market Trends Market Forecast
10.3 Europe
10.3.1 Germany Market Trends Market Forecast
10.3.2 France Market Trends Market Forecast
10.3.3 United Kingdom Market Trends Market Forecast
10.3.4 Italy Market Trends Market Forecast
10.3.5 Spain Market Trends Market Forecast
10.3.6 Russia Market Trends Market Forecast
10.3.7 Others Market Trends Market Forecast
10.4 Latin America
10.4.1 Brazil Market Trends Market Forecast
10.4.2 Mexico Market Trends Market Forecast
10.4.3 Others Market Trends Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 B. Braun Melsungen AG Company Overview Product Portfolio SWOT Analysis
15.3.2 Baxter International Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.3 Becton Dickinson and Company Company Overview Product Portfolio Financials SWOT Analysis
15.3.4 CryoLife Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.5 CSL Limited Company Overview Product Portfolio Financials SWOT Analysis
15.3.6 Hemostasis LLC Company Overview Product Portfolio
15.3.7 Integra Lifesciences Holdings Corporation Company Overview Product Portfolio Financials SWOT Analysis
15.3.8 Johnson & Johnson Company Overview Product Portfolio Financials SWOT Analysis
15.3.9 Medtronic plc Company Overview Product Portfolio Financials SWOT Analysis
15.3.10 Pfizer Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.11 Sanofi S.A. Company Overview Product Portfolio Financials SWOT Analysis
15.3.12 Smith & Nephew plc Company Overview Product Portfolio Financials SWOT Analysis
15.3.13 Stryker Corporation Company Overview Product Portfolio Financials SWOT Analysis
15.3.14 Surgalign Spine Technologies Inc. Company Overview Product Portfolio Financials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings